标题 |
Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2- early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2- trial
|
网址 | |
DOI | |
其它 |
期刊:Annals of oncology : official journal of the European Society for Medical Oncology 作者:Gluz O; Kuemmel S; Nitz U; Braun M; Lüdtke-Heckenkamp K; et al 出版日期:2023/04/14 |
求助人 | |
下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |